Intratumoral heterogeneity and clonal evolution in liver cancer

Journal: Nature Communications

Published: 2020-01-15

DOI: 10.1038/s41467-019-14050-z

Affiliations: 22

Authors: 28

Go to article
Institutions Share
Tisch Cancer Institute (TCI), ISMMS, United States of America (USA) 0.20
Department of Surgery, ISMMS, United States of America (USA) 0.11
Department of Genetics and Genomic Sciences, ISMMS, United States of America (USA) 0.11
Lillian and Henry M. Stratton-Hans Popper Department of Pathology, ISMMS, United States of America (USA) 0.11
Graduate School of Biomedical Sciences, ISMMS, United States of America (USA) 0.10
Division of Liver Diseases, ISMMS, United States of America (USA) 0.10
Precision Immunology Institute, ISMMS, United States of America (USA) 0.07
Icahn Institute for Data Science and Genomic Technology, ISMMS, United States of America (USA) 0.05
Department of Pathology, Dalhousie University, Canada 0.04
Sema4, Inc., United States of America (USA) 0.03
IBM Thomas J. Watson Research Center, United States of America (USA) 0.01
Adaptive Biotechnologies LLC, United States of America (USA) 0.01
Division of Hematology and Medical Oncology, ISMMS, United States of America (USA) 0.01
University Hospital of Lausanne (CHUV), UNIL, Switzerland 0.01
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany 0.01
School of Medicine, USP, Brazil 0.01
Diabetes, Obesity and Metabolism Institute (DOMI), ISMMS, United States of America (USA) 0.01
Clínica Universidad de Navarra (CUN), UNAV, Spain 0.01
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain 0.01
Catalan Institution for Research and Advanced Studies (ICREA), Spain 0.01
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD), Spain 0.01

Return